State of Wisconsin Investment Board’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
59,575
+46,820
+367% +$1.25M ﹤0.01% 1438
2025
Q4
$368K Sell
12,755
-58,800
-82% -$768K ﹤0.01% 2082
2025
Q3
$516K Buy
+71,555
New +$527K ﹤0.01% 1877
2025
Q2
Sell
-23,662
Closed -$225K 2333
2025
Q1
$225K Hold
23,662
﹤0.01% 2082
2024
Q4
$327K Buy
+23,662
New +$415K ﹤0.01% 1979

Other funds holding CAPR

State of Wisconsin Investment Board's CAPR Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Capricor Therapeutics (CAPR) stake by 367% in Q1 2026, buying an estimated $1.25M and bringing the position to 59,575 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

State of Wisconsin Investment Board first reported a position in CAPR in Q4 2024 and has held it in 5 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • State of Wisconsin Investment Board held 59,575 shares of Capricor Therapeutics worth $1.81M as of Q1 2026.
  • State of Wisconsin Investment Board bought 46,820 Capricor Therapeutics shares in Q1 2026, an estimated $1.25M.
  • Capricor Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1438 holding.
  • State of Wisconsin Investment Board first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.